$BCRX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in BIOCRYST PHARMACEUTICALS INC. Get notifications about new insider transactions in BIOCRYST PHARMACEUTICALS INC for free.

Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 03 2016	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	2.13	2,761	5,881	664,585	667.3 K to 664.6 K (-0.41 %)
Mar 01 2016	BCRX	BIOCRYST PHARMACEU ...	SANDERS CHARLES A	Director	Grant	A	1.99	4,396	8,748	12,971	8.6 K to 13 K (+51.27 %)
Mar 01 2016	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	1.99	4,396	8,748	21,862	17.5 K to 21.9 K (+25.17 %)
Mar 01 2016	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	1.99	4,396	8,748	109,065	104.7 K to 109.1 K (+4.20 %)
Feb 09 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.33	45,000	284,657	12,894,240	12.8 M to 12.9 M (+0.35 %)
Feb 04 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.65	24,800	164,915	12,849,240	12.8 M to 12.8 M (+0.19 %)
Feb 04 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.29	91,187	573,311	12,824,440	12.7 M to 12.8 M (+0.72 %)
Feb 04 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.52	91,728	598,360	12,733,253	12.6 M to 12.7 M (+0.73 %)
Feb 01 2016	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	M	1.42	19,368	27,503	20,632
Feb 01 2016	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Buy	M	1.42	19,368	27,503	85,057	65.7 K to 85.1 K (+29.48 %)
Jan 29 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.88	25,000	172,015	12,641,525	12.6 M to 12.6 M (+0.20 %)
Jan 29 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.98	63,345	441,971	12,616,525	12.6 M to 12.6 M (+0.50 %)
Jan 27 2016	BCRX	BIOCRYST PHARMACEU ...	Powell Lynne	Senior VP - CCO	Payment of Exercise	F	7.29	3,850	28,067	8,605	12.5 K to 8.6 K (-30.91 %)
Jan 25 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	7.00	3,200	22,389	12,553,180	12.5 M to 12.6 M (+0.03 %)
Jan 25 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	7.29	103,600	755,368	12,549,980	12.4 M to 12.5 M (+0.83 %)
Jan 22 2016	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	7.55	2,599	19,622	65,689	68.3 K to 65.7 K (-3.81 %)
Jan 22 2016	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	7.55	4,724	35,666	142,334	147.1 K to 142.3 K (-3.21 %)
Jan 22 2016	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Payment of Exercise	F	7.55	5,359	40,460	88,967	94.3 K to 89 K (-5.68 %)
Jan 22 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	7.55	4,823	36,414	145,093	149.9 K to 145.1 K (-3.22 %)
Jan 22 2016	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	7.55	10,624	80,211	665,702	676.3 K to 665.7 K (-1.57 %)
Jan 21 2016	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	M	4.15	24,096	99,998	134,279
Jan 21 2016	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Buy	M	4.15	24,096	99,998	676,326	652.2 K to 676.3 K (+3.69 %)
Jan 21 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	1.42	12,500	17,750	87,500
Jan 21 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	2,500	9,450	99,260
Jan 21 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	1.42	12,500	17,750	149,916	137.4 K to 149.9 K (+9.10 %)
Jan 21 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	2,500	9,450	137,416	134.9 K to 137.4 K (+1.85 %)
Jan 20 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.94	1,325	9,197	12,446,380	12.4 M to 12.4 M (+0.01 %)
Jan 20 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	6.87	51,370	352,974	12,445,055	12.4 M to 12.4 M (+0.41 %)
Jan 20 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	7.12	92,200	656,750	12,393,685	12.3 M to 12.4 M (+0.75 %)
Jan 20 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	7.49	25,000	187,333	12,301,485	12.3 M to 12.3 M (+0.20 %)
Jan 20 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Buy	P	7.45	175,000	1,303,890	12,276,485	12.1 M to 12.3 M (+1.45 %)
Jan 05 2016	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	10.32	1,281	13,220	68,288	69.6 K to 68.3 K (-1.84 %)
Jan 05 2016	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	10.32	1,639	16,914	147,058	148.7 K to 147.1 K (-1.10 %)
Jan 05 2016	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Payment of Exercise	F	10.32	2,081	21,476	94,326	96.4 K to 94.3 K (-2.16 %)
Jan 05 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	10.32	1,676	17,296	134,916	136.6 K to 134.9 K (-1.23 %)
Jan 05 2016	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	10.32	8,091	83,499	652,230	660.3 K to 652.2 K (-1.23 %)
Dec 31 2015	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	A	10.82	43,997	476,048	43,997
Dec 31 2015	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	10.82	62,573	677,040	62,573
Dec 31 2015	BCRX	BIOCRYST PHARMACEU ...	Powell Lynne	Senior VP - CCO	Option Exercise	A	10.82	62,573	677,040	62,573
Dec 31 2015	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	10.82	71,698	775,772	71,698
Dec 31 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	10.82	62,573	677,040	62,573
Dec 31 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	10.82	162,950	1,763,119	162,950
Dec 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	10.86	3,052	33,145	136,592	139.6 K to 136.6 K (-2.19 %)
Dec 18 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	10.49	3,000	31,470	139,644	142.6 K to 139.6 K (-2.10 %)
Dec 03 2015	BCRX	BIOCRYST PHARMACEU ...	SANDERS CHARLES A	Director	Grant	A	10.61	824	8,743	8,575	7.8 K to 8.6 K (+10.63 %)
Dec 03 2015	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	10.61	824	8,743	17,466	16.6 K to 17.5 K (+4.95 %)
Dec 03 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	10.61	824	8,743	104,669	103.8 K to 104.7 K (+0.79 %)
Sep 29 2015	BCRX	BIOCRYST PHARMACEU ...	Patel Sanj K	Director	Option Exercise	A	11.18	16,667	186,337	16,667
Sep 02 2015	BCRX	BIOCRYST PHARMACEU ...	SANDERS CHARLES A	Director	Grant	A	11.64	751	8,742	7,751	7 K to 7.8 K (+10.73 %)
Sep 02 2015	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	11.64	751	8,742	16,642	15.9 K to 16.6 K (+4.73 %)
Sep 02 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	11.64	751	8,742	103,845	103.1 K to 103.8 K (+0.73 %)
Aug 07 2015	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Option Exercise	A	14.88	18,750	279,000	18,750
Jul 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	16.50	3,500	57,750	142,644	146.1 K to 142.6 K (-2.39 %)
Jul 17 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	M	11.81	33,868	399,981	416,132
Jul 17 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	15.67	25,526	399,992	659,211	684.7 K to 659.2 K (-3.73 %)
Jul 17 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Buy	M	11.81	33,868	399,981	684,737	650.9 K to 684.7 K (+5.20 %)
Jun 24 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	4.73	3,750	17,738	11,750
Jun 24 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	16.00	3,750	60,000	146,144	149.9 K to 146.1 K (-2.50 %)
Jun 24 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	4.73	3,750	17,738	149,894	146.1 K to 149.9 K (+2.57 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Sell	S	15.00	3,000	45,000	68,876	71.9 K to 68.9 K (-4.17 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	M	2.58	70,389	181,604	42,112
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Sell	S	15.05	70,389	1,059,354	95,123	165.5 K to 95.1 K (-42.53 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Buy	M	1.20	70,389	84,467	165,512	95.1 K to 165.5 K (+74.00 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	3,175	12,002	101,760
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	3,100	11,718	104,935
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	3,100	11,718	108,035
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	15.00	3,175	47,625	146,144	149.3 K to 146.1 K (-2.13 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	3,175	12,002	149,319	146.1 K to 149.3 K (+2.17 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	15.00	3,500	52,500	146,144	149.6 K to 146.1 K (-2.34 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	13.50	3,100	41,850	149,644	152.7 K to 149.6 K (-2.03 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	14.25	3,100	44,175	152,744	155.8 K to 152.7 K (-1.99 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	3,100	11,718	155,844	152.7 K to 155.8 K (+2.03 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	3,100	11,718	152,744	149.6 K to 152.7 K (+2.07 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	14.00	3,500	49,000	149,644	153.1 K to 149.6 K (-2.29 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	M	1.20	20,000	24,000	80,000
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Sell	S	15.02	20,000	300,400	650,869	670.9 K to 650.9 K (-2.98 %)
Jun 22 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Buy	M	1.20	20,000	24,000	670,869	650.9 K to 670.9 K (+3.07 %)
Jun 16 2015	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	A	5.45	17,000	92,650	17,000
Jun 16 2015	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	5.45	17,000	92,650	17,000
Jun 16 2015	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	5.45	17,000	92,650	17,000
Jun 16 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	5.45	17,000	92,650	17,000
Jun 16 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	5.45	25,000	136,250	25,000
Jun 09 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	12.75	6,000	76,500	153,144	159.1 K to 153.1 K (-3.77 %)
Jun 02 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	12.00	3,000	36,000	159,144	162.1 K to 159.1 K (-1.85 %)
Jun 01 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	11.21	780	8,744	103,094	102.3 K to 103.1 K (+0.76 %)
May 22 2015	BCRX	BIOCRYST PHARMACEU ...	SANDERS CHARLES A	Director	Option Exercise	A	11.39	15,000	170,850	15,000
May 22 2015	BCRX	BIOCRYST PHARMACEU ...	LEE KENNETH B JR	Director	Option Exercise	A	11.39	15,000	170,850	15,000
May 22 2015	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Option Exercise	A	11.39	15,000	170,850	15,000
May 22 2015	BCRX	BIOCRYST PHARMACEU ...	Erck Stanley C	Director	Option Exercise	A	11.39	15,000	170,850	15,000
May 22 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	A	11.39	15,000	170,850	15,000
May 22 2015	BCRX	BIOCRYST PHARMACEU ...	ABERCROMBIE GEORGE B	Director	Option Exercise	A	11.39	15,000	170,850	15,000
May 19 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	11.00	3,000	33,000	162,144	165.1 K to 162.1 K (-1.82 %)
Mar 20 2015	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Sell	S	10.16	12,105	122,987	148,697	160.8 K to 148.7 K (-7.53 %)
Mar 06 2015	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Sell	S	10.59	37,400	396,066	160,802	198.2 K to 160.8 K (-18.87 %)
Mar 05 2015	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Sell	S	10.50	10,495	110,198	198,202	208.7 K to 198.2 K (-5.03 %)
Mar 03 2015	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	10.20	1,120	11,424	71,876	73 K to 71.9 K (-1.53 %)
Mar 03 2015	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	10.20	1,634	16,667	208,697	210.3 K to 208.7 K (-0.78 %)
Mar 03 2015	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Payment of Exercise	F	10.20	1,739	17,738	95,123	96.9 K to 95.1 K (-1.80 %)
Mar 03 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	10.20	465	4,743	165,144	165.6 K to 165.1 K (-0.28 %)
Mar 03 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	10.20	5,118	52,204	650,869	656 K to 650.9 K (-0.78 %)
Mar 03 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	10.20	857	8,741	102,314	101.5 K to 102.3 K (+0.84 %)
Feb 23 2015	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Buy	P	10.27	10,000	102,700	15,891	5.9 K to 15.9 K (+169.75 %)
Jan 28 2015	BCRX	BIOCRYST PHARMACEU ...	Powell Lynne	Senior VP - CCO	Option Exercise	A	11.33	190,000	2,152,700	190,000
Jan 28 2015	BCRX	BIOCRYST PHARMACEU ...	Powell Lynne	Senior VP - CCO	Grant	A	0.00	10,000	0	10,000	0 to 10 K
Jan 22 2015	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	11.17	2,210	24,686	72,370	74.6 K to 72.4 K (-2.96 %)
Jan 22 2015	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	11.17	4,362	48,724	210,331	214.7 K to 210.3 K (-2.03 %)
Jan 22 2015	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Payment of Exercise	F	11.17	5,074	56,677	95,609	100.7 K to 95.6 K (-5.04 %)
Jan 22 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	11.17	4,476	49,997	164,913	169.4 K to 164.9 K (-2.64 %)
Jan 22 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	11.17	10,608	118,491	654,280	664.9 K to 654.3 K (-1.60 %)
Jan 09 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	M	1.29	100,000	129,000	0
Jan 09 2015	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Buy	M	1.29	100,000	129,000	101,457	1.5 K to 101.5 K (+6,863.42 %)
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	A	12.16	23,200	282,112	23,200
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	12.16	2,453	29,828	74,580	77 K to 74.6 K (-3.18 %)
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Grant	A	0.00	4,800	0	77,033	72.2 K to 77 K (+6.65 %)
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	12.16	42,400	515,584	42,400
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	12.16	2,402	29,208	214,693	217.1 K to 214.7 K (-1.11 %)
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Grant	A	0.00	8,900	0	217,095	208.2 K to 217.1 K (+4.27 %)
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	12.16	52,000	632,320	52,000
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Payment of Exercise	F	12.16	2,735	33,258	100,683	103.4 K to 100.7 K (-2.64 %)
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Grant	A	0.00	10,900	0	103,418	92.5 K to 103.4 K (+11.78 %)
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	12.16	42,400	515,584	42,400
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	12.16	2,453	29,828	169,389	171.8 K to 169.4 K (-1.43 %)
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Grant	A	0.00	8,900	0	171,842	162.9 K to 171.8 K (+5.46 %)
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	12.16	5,652	68,728	664,888	670.5 K to 664.9 K (-0.84 %)
Jan 05 2015	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Grant	A	0.00	28,400	0	670,540	642.1 K to 670.5 K (+4.42 %)
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	M	1.42	23,104	32,808	62,500
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	M	1.42	14,396	20,442	85,604
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	M	5.45	17,000	92,650	0
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	M	5.45	17,000	92,650	0
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Sell	S	12.06	23,104	278,634	92,518	115.6 K to 92.5 K (-19.98 %)
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Buy	M	1.42	23,104	32,808	115,622	92.5 K to 115.6 K (+24.97 %)
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Sell	S	12.43	105,295	1,308,817	92,518	197.8 K to 92.5 K (-53.23 %)
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Buy	M	1.42	14,396	20,442	197,813	183.4 K to 197.8 K (+7.85 %)
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Buy	M	5.45	17,000	92,650	183,417	166.4 K to 183.4 K (+10.22 %)
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Buy	M	5.45	17,000	92,650	166,417	149.4 K to 166.4 K (+11.38 %)
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	9,500	35,910	111,135
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	12.56	9,500	119,320	162,942	172.4 K to 162.9 K (-5.51 %)
Dec 31 2014	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	9,500	35,910	172,442	162.9 K to 172.4 K (+5.83 %)
Dec 23 2014	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	A	5.45	17,000	92,650	17,000
Dec 23 2014	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	5.45	17,000	92,650	17,000
Dec 23 2014	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	5.45	17,000	92,650	17,000
Dec 23 2014	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	5.45	17,000	92,650	17,000
Dec 23 2014	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	5.45	25,000	136,250	25,000
Dec 03 2014	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	10.81	809	8,745	1,457	648 to 1.5 K (+124.85 %)
Sep 02 2014	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	13.50	648	8,748	648	0 to 648
Aug 29 2014	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	5.45	10,000	54,500	7,000
Aug 29 2014	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	13.58	10,000	135,800	162,942	172.9 K to 162.9 K (-5.78 %)
Aug 29 2014	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	5.45	10,000	54,500	172,942	162.9 K to 172.9 K (+6.14 %)
Jul 28 2014	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	26,455	100,000	120,635
Jul 28 2014	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	11.76	8,504	100,007	162,252	170.8 K to 162.3 K (-4.98 %)

Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >